Created at	Source	Raw Value	Validated value
Oct. 17, 2022, 10:36 a.m.	usa	Occurrence of adverse events (AEs) in Safety Sub-study;Occurrence of adverse events of special interest (AESIs) in Safety Sub-study;Occurrence of disease related events (DREs) in Safety Sub-study;Occurrence of serious adverse events (SAEs) in Safety Sub-study;Progression of COVID-19 in Main Study	Occurrence of adverse events (AEs) in Safety Sub-study;Occurrence of adverse events of special interest (AESIs) in Safety Sub-study;Occurrence of disease related events (DREs) in Safety Sub-study;Occurrence of serious adverse events (SAEs) in Safety Sub-study;Progression of COVID-19 in Main Study
June 8, 2021, 12:32 a.m.	usa	Proportion of participants who have progression of COVID-19	Proportion of participants who have progression of COVID-19